EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Evaluating Critical Success Factors in AI-Driven Drug Discovery Using AHP: A Strategic Framework for Optimization

Amir Mohamed Talib, Areen Metib Al-Hgaish, Rodziah Binti Atan, Abdulaziz Alshammari, Fahad Omar Alomary, Razali Yaakob, Abdulaziz Alsahli, Mohd Hafeez Osman

IEEE Access · 2025 · 13 · 42045-42063

DOI: 10.1109/access.2025.3546925 ↗

Kurz gefasst

Fachartikel in der Zeitschrift IEEE Access, 2025. Verfasst von Amir Mohamed Talib und 7 weiteren Autor:innen. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 140 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deanship of Scientific Research at Imam Mohammad Ibn Saud Islamic University.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Artificial Intelligence (AI) is reshaping drug discovery by accelerating the identification of therapeutic candidates and reducing development timelines and costs. However, its effectiveness depends on addressing key success factors that influence AI integration. This study presents a novel framework using the Analytic Hierarchy Process (AHP) to systematically evaluate and rank these factors, addressing a crucial gap in strategic planning for AI adoption in pharmaceutical research. The framework comprises six key criteria: Data Quality and Management (DQM), Algorithm Performance and Optimization (APO), Interpretability and Explainability (IE), Regulatory Compliance and Ethical Considerations (RCEC), Computational Efficiency and Scalability (CES), and Validation and Experimental Confirmation (VEC). Expert-driven pairwise comparisons identified Accuracy (ACC), Generalizability (GEN), and Experimental Validation (EV) as top priorities, highlighting the importance of reliable data, robust algorithms, and rigorous validation processes to ensure trustworthy AI outputs. This research contributes to strategic AI adoption by addressing data inconsistencies, algorithmic bias, and scalability limitations. The proposed framework enhances AI applications’ efficiency, scalability, and ethical alignment, promoting the development of transparent and reliable drug discovery systems. This comprehensive evaluation is a valuable resource for researchers and industry professionals, facilitating the strategic adoption of AI and bridging the gap between computational predictions and real-world therapeutic outcomes.

Förderung

  • Deanship of Scientific Research at Imam Mohammad Ibn Saud Islamic University

Zitieren

APA

Talib, A. M., Al-Hgaish, A. M., Atan, R. B., Alshammari, A., Alomary, F. O., Yaakob, R., Alsahli, A., & Osman, M. H. (2025). Evaluating Critical Success Factors in AI-Driven Drug Discovery Using AHP: A Strategic Framework for Optimization. IEEE Access, 13, 42045-42063. https://doi.org/10.1109/access.2025.3546925

Vancouver

Talib AM, Al-Hgaish AM, Atan RB, Alshammari A, Alomary FO, Yaakob R, et al. Evaluating Critical Success Factors in AI-Driven Drug Discovery Using AHP: A Strategic Framework for Optimization. IEEE Access. 2025;13:42045-42063. doi:10.1109/access.2025.3546925

BibTeX
@article{Talib2025,
  author = {Talib, Amir Mohamed and Al-Hgaish, Areen Metib and Atan, Rodziah Binti and Alshammari, Abdulaziz and Alomary, Fahad Omar and Yaakob, Razali and Alsahli, Abdulaziz and Osman, Mohd Hafeez},
  title = {Evaluating Critical Success Factors in AI-Driven Drug Discovery Using AHP: A Strategic Framework for Optimization},
  journal = {IEEE Access},
  year = {2025},
  volume = {13},
  pages = {42045--42063},
  doi = {10.1109/access.2025.3546925}
}
Kostenlos starten →